CSF liquid biopsy testing for primary and metastatic CNS malignancies, providing clinicians and patients a minimally invasive alternative to tissue biopsy.
Employees: 1-10
Founded date: 2022
Investors 1
| Date | Name | Website |
| 10.11.2023 | Johns Hopk... | ventures.j... |
Mentions in press and media 1
| Date | Title | Description |
| 15.01.2026 | The End Brain Cancer Initiative Partners with Belay Diagnostics to Raise Awareness of Diagnostic Testing for CNS Tumors | Belay Diagnostics REDMOND, WA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The End Brain Cancer Initiative Partners with Belay Diagnostics to Raise Awareness of Diagnostic Testing for CNS Tumors The End Brain Cancer Initiative (EB... |